Physician profile
Travis Williams
NPI 1992435143
$695.97
in general payments reported to CMS, 2019-2025
20 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $281 · 2024: $279 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $125.33 | 2023-2025 | |
| Novo Nordisk INC | $78.18 | 2023-2024 | Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $55.25 | 2023 | Gemtesa |
| Glaxosmithkline, LLC. | $44.71 | 2023 | Shingrix, Arexvy |
| Viatris Specialty LLC | $44.48 | 2025 | Yupelri |
| Exact Sciences Corporation | $44.46 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $41.05 | 2024 | Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $39.09 | 2024 | Ajovy, Austedo Xr |
| Insulet Corporation | $32.97 | 2025 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $22.30 | 2023 | Rexulti |
| Eisai INC. | $21.90 | 2024 | |
| Ani Pharmaceuticals, INC. | $20.17 | 2025 | Purified Cortrophin Gel |
| Lundbeck LLC | $18.81 | 2023 | Vyepti |
| Impel Pharmaceuticals INC. | $18.48 | 2023 | Trudhesa |
| Neos Therapeutics, LP | $17.98 | 2024 | Adzenys Xr-Odt |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $17.87 | 2023 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $15.75 | 2024 | Airsupra |
| Mylan Specialty L.P. | $14.39 | 2024 | Yupelri |
| Philips North America LLC | $13.27 | 2024 | (8874) Incourage |
| Phathom Pharmaceuticals, INC. | $9.53 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.